Friday, October 7, 2022 | Back issues
Courthouse News Service Courthouse News Service

Big Pharma Securities

MANHATTAN - A federal judge dismissed two securities complaints against Genzyme-successor Sanofi regarding statements about the multiple sclerosis drug Lemtrada.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.